AC
PRAH

Aristides Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Aristides Capital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,834
Closed -$648K – 283
2019
Q4 		$648K Buy
+5,834
New +$600K 0.5% 61

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Aristides Capital's PRAH Position: Q1 2020 in Review

Aristides Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 5,834 shares — an estimated $648K sold.

Aristides Capital first reported a position in PRAH in Q4 2019 and held it in 1 quarter. The position peaked at $648K in Q4 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Aristides Capital reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Aristides Capital sold 5,834 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $648K.
  • Aristides Capital first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 1 quarter.
  • Aristides Capital's PRA Health Sciences, Inc. position peaked at $648K in Q4 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Aristides Capital's 13F filing for Q1 2020, filed 15 May 2020.